Fig. 3
From: A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma
snoRNAs: SNORD15A, SNORD35B and SNORD60 as non-invasive diagnostic biomarkers for RCC. (A): Stability of snoRNAs in US: there was no statistical difference in the expression of SNORD15A, SNORD35B and SNORD60 between the control group (without RNase treatment) and the RNase group (with RNase treatment). (B): SNORD15A, SNORD35B and SNORD60 were up-regulated in US of RCC patients (n = 100) compared with healthy controls (n = 131); (C): ROC curve analysis of SNORD15A, SNORD35B and SNORD60 and their combination for RCC diagnosis. ****P < 0.0001; NS, no significance